European Case Law Identifier: | ECLI:EP:BA:2001:T082196.20010425 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 25 April 2001 | ||||||||
Case number: | T 0821/96 | ||||||||
Application number: | 91917994.5 | ||||||||
IPC class: | C07D 213/56 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Piperazine Derivatives | ||||||||
Applicant name: | JOHN WYETH & BROTHER LIMITED | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.01 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Clarity and support within the meaning of Article 84 EPC (yes, after amendments) Reimbursement of the appeal fee (no) - outcome of the decision not affected - equity within the meaning of Rule 67 EPC (no) Inventive step (yes, afer amendment) - non-obvious improvement |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t960821eu1.html
Date retrieved: 17 May 2021